)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Mayne Pharma Group
Mayne Pharma Group (MYX) investor relations material
Mayne Pharma Group H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary22 Feb, 2026
Executive summary
Revenue for H1 FY26 was $212.1m (AUD 212.1m), down 0.5% year-over-year, with resilient earnings and disciplined margin management despite transaction-related uncertainty.
Gross margin improved to 65.3% from 61.4% in the prior period, driven by favorable product mix, especially in Dermatology.
Underlying EBITDA was $28.6m, down 8% year-over-year, reflecting higher investment in Women's Health and international expansion.
Net loss after tax narrowed to $12.1m from $20.0m in the prior period, a 40% improvement.
Leadership transition announced, with Aaron Gray appointed CEO, succeeding Shawn Patrick O'Brien, and ongoing search for CFO.
Financial highlights
Revenue: $212.1m (down 0.5% year-over-year); Gross profit: $138.6m (up 6% year-over-year); Gross margin: 65.3% (up from 61.4%).
Underlying EBITDA: $28.6m (down 8% year-over-year); Adjusted EBITDA: $63.0m, reflecting significant non-operating items.
Adjusted operating cash flow from continuing operations: $16.9m (down 38% year-over-year).
Cash and marketable securities at period end: $67.4m.
Net loss from continuing operations: $12.1m (improved from $20.0m loss year-over-year).
Outlook and guidance
Focus on market share growth in Women's Health, leveraging refreshed marketing and product access, and protecting IP.
Dermatology to advance disintermediation strategy and expand into new therapeutic areas.
International segment to unlock value from NEXTSTELLIS PBS listing, CapEx investments, and supply agreements.
Continued investment in existing assets and product launches to support future revenue streams.
CFO search timeline and impact on governance?
Details on Q3 FY26 disintermediation strategy?
When will International investment yield contribution?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Mayne Pharma Group earnings date
H2 202627 Aug, 2026
Mayne Pharma Group
Next Mayne Pharma Group earnings date
H2 202627 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Mayne Pharma Group Limited is an Australian pharmaceutical company engaged in the development, manufacturing, and distribution of branded and generic pharmaceutical products. The company’s portfolio spans various therapeutic areas, including women’s health, dermatology, and pain management, with products available in oral, topical, and injectable forms. Mayne Pharma operates manufacturing facilities in Australia and the United States, and its services include contract development and manufacturing for other pharmaceutical companies. The company is headquartered in Salisbury, South Australia, and its shares are listed on the Australian Securities Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage